Premium
Safety and efficacy of a novel short occlusive regimen of imiquimod for selected non‐melanotic skin lesions in renal transplant patients
Author(s) -
Das G.,
Tan B.,
Nicholls K.
Publication year - 2016
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.13004
Subject(s) - medicine , imiquimod , cosmesis , renal transplant , dermatology , actinic keratosis , regimen , transplantation , skin cancer , surgery , cancer , basal cell
Australian patients remain at very high risk of non‐melanotic skin cancer after renal transplantation. Surgical excision offers a cure but destroys tissue and may jeopardise function and cosmesis. We report excellent safety and efficacy using topical imiquimod in a novel short intensive regimen in 10 renal transplant patients with superficial basal cell carcinomas, Bowen disease or actinic keratosis. Outcomes compare well to those reported with extended‐use imiquimod protocols.